Sharmila Banerjee

9PUBLICATIONS
6CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Reaction engineering (excl. nuclear reactions)Nuclear engineering (incl. fuel enrichment and waste processing and storage)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 03, 2026
Design and development of a semi-automated solid target assembly for the indigenous production of medical radioisotopes in the PETrace-800 cyclotron.

|Apr 20, 2026
Rhenium-186-labeled <i>ortho</i>-hydroxythiobenzhydrazide: a potential theranostic agent for use in metastatic breast cancer.

|May 16, 2022
Clinical Dose Preparation of [<sup>177</sup>Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [<sup>177</sup>Lu]LuCl<sub>3</sub> for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor Overexpression.

Sreeja Raj Menon, Arpit Mitra, Avik Chakraborty

|Apr 25, 2022
Automated radiochemical synthesis of pharmaceutical grade [<sup>18</sup> F]FLT using 3-N-Boc-5'-O-dimethoxytrityl-3'-O-nosyl-thymidine precursor and its Sep-Pak® purification employing selective elution from reversed phase.

Arpit Mitra, Avik Chakraborty, Trupti Upadhye

|Dec 15, 2021
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [<sup>177</sup>Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles.

Kamaldeep, Sarvesh Loharkar, Tapas Das

|Aug 17, 2021
Therapeutic Multidose Preparation of a Ready-to-Use <sup>177</sup>Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy.

Avik Chakraborty, Arpit Mitra, Megha Tawate

Pageof 2

Frequent Collaborators

1 joint publications

Drishty Satpati

1 joint publications

Chandan Kumar

1 joint publications

Tapas Das

1 joint publications

Sandip Basu